{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:51Z","timestamp":1794047391885,"version":"4.8.0"},"reference-count":16,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"12","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2021.279033","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T03:10:23Z","timestamp":1629947423000},"page":"3219-3222","source":"Crossref","is-referenced-by-count":26,"title":["Allogeneic hematopoietic cell transplantation outcomes in patients with Richter\u2019s transformation"],"prefix":"10.3324","volume":"106","author":[{"given":"Haesook T.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter O.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Davids","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Alyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahasweta","family":"Gooptu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Romee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nikiforow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"32348","doi-asserted-by":"crossref","unstructured":"Wang Y, Tschautscher MA, Rabe KG. Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center. Haematologica. 2020; 105(3):765-773.","DOI":"10.3324\/haematol.2019.224121"},{"key":"32349","doi-asserted-by":"crossref","unstructured":"Rossi D, Spina V, Gaidano G. Biology and treatment of Richter syndrome. Blood. 2018; 131(25):2761-2772.","DOI":"10.1182\/blood-2018-01-791376"},{"key":"32350","doi-asserted-by":"crossref","unstructured":"Allan JN, Furman RR. Current trends in the management of Richter's syndrome. Int J Hematol Oncol. 2019; 7(4):IJH09.","DOI":"10.2217\/ijh-2018-0010"},{"key":"32351","doi-asserted-by":"crossref","unstructured":"Kadri S, Lee J, Fitzpatrick C. Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Adv. 2017; 1(12):715-727.","DOI":"10.1182\/bloodadvances.2016003632"},{"key":"32352","doi-asserted-by":"crossref","unstructured":"Maddocks KJ, Ruppert AS, Lozanski G. Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia. JAMA Oncol. 2015; 1(1):80-87.","DOI":"10.1001\/jamaoncol.2014.218"},{"key":"32353","doi-asserted-by":"crossref","unstructured":"Jain P, Thompson PA, Keating M. Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib. Cancer. 2017; 123(12):2268-2273.","DOI":"10.1002\/cncr.30596"},{"key":"32354","doi-asserted-by":"crossref","unstructured":"Dreger P, Schnaiter A, Zenz T. TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial. Blood. 2013; 121(16):3284-3288.","DOI":"10.1182\/blood-2012-11-469627"},{"key":"32355","doi-asserted-by":"crossref","unstructured":"Dreger P, Montserrat E. European Society for Blood and Marrow Transplantation (EBMT); European Research Initiative on CLL (ERIC). Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?. Curr Hematol Malig Rep. 2015; 10(1):59-64.","DOI":"10.1007\/s11899-014-0242-1"},{"key":"32356","doi-asserted-by":"crossref","unstructured":"Tsimberidou AM, O\u2019Brien S, Khouri I. Clinical outcomes and prognostic factors in patients with Richter\u2019s syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J Clin Oncol. 2006; 24(15):2343-2351.","DOI":"10.1200\/JCO.2005.05.0187"},{"key":"32357","doi-asserted-by":"crossref","unstructured":"Cwynarski K, Van Biezen A, De Wreede L. Autologous and allogeneic stem-cell transplantation for transformed chroniclymphocytic leukemia (Richter\u2019s syndrome): a retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronicleukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2012; 30(18):2211-2217.","DOI":"10.1200\/JCO.2011.37.4108"},{"key":"32358","doi-asserted-by":"crossref","unstructured":"Kharfan-Dabaja MA, Kumar A, Stingo F. Allogeneic hematopoietic cell transplantation for richter syndrome: a single-centerexperience. Clin. Lymphoma. Myeloma Leuk. 2018; 18(1):e35-e39.","DOI":"10.1016\/j.clml.2017.10.002"},{"key":"32359","doi-asserted-by":"crossref","unstructured":"Kim HT, Ahn KW, Hu ZH. Prognostic score and cytogenetic risk classification for reduced intensity conditioning allogeneic HCT in CLL patients: CIBMTR report. Clin Cancer Res. 2019; 25(16):5143-5155.","DOI":"10.1158\/1078-0432.CCR-18-3988"},{"key":"32360","doi-asserted-by":"crossref","unstructured":"Kim HT, Shaughnessy CJ, Rai SC. Outcome of high-risk chronic lymphocytic leukemia patients undergoing allogeneic hematopoietic cell transplant after prior targeted therapy. Blood Adv. 2020; 4(17):4113-4123.","DOI":"10.1182\/bloodadvances.2020002184"},{"key":"32361","doi-asserted-by":"crossref","unstructured":"Fenske T, Ahn K, Graff T. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. Br J Haematol. 2016; 174(2):235-248.","DOI":"10.1111\/bjh.14046"},{"key":"32362","doi-asserted-by":"crossref","unstructured":"Kittai AS, Bond DA, William B. Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome. Blood Adv. 2020; 4(19):4648-4652.","DOI":"10.1182\/bloodadvances.2020002783"},{"key":"32363","doi-asserted-by":"crossref","unstructured":"Rossi D, Spina V, Deambrogi C. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood. 2011; 117(12):3391-3401.","DOI":"10.1182\/blood-2010-09-302174"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279033\/73647","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279033\/73914","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10391\/73647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:00:18Z","timestamp":1794045618000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.279033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.279033","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,26]]}}}